Gina T. Mootrey

3.7k total citations · 1 hit paper
27 papers, 2.9k citations indexed

About

Gina T. Mootrey is a scholar working on Infectious Diseases, Epidemiology and Health. According to data from OpenAlex, Gina T. Mootrey has authored 27 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 12 papers in Epidemiology and 11 papers in Health. Recurrent topics in Gina T. Mootrey's work include SARS-CoV-2 and COVID-19 Research (12 papers), Vaccine Coverage and Hesitancy (11 papers) and Viral gastroenteritis research and epidemiology (6 papers). Gina T. Mootrey is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (12 papers), Vaccine Coverage and Hesitancy (11 papers) and Viral gastroenteritis research and epidemiology (6 papers). Gina T. Mootrey collaborates with scholars based in United States. Gina T. Mootrey's co-authors include John K. Iskander, Anthony E. Fiore, Joseph Bresee, Karen R. Broder, Nancy J. Cox, David K. Shay, Timothy M. Uyeki, Robert T. Chen, M. Miles Braun and Penina Haber and has published in prestigious journals such as Annals of Internal Medicine, PEDIATRICS and Clinical Infectious Diseases.

In The Last Decade

Gina T. Mootrey

26 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.

2009 1.7k citations Gina T. Mootrey et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gina T. Mootrey United States	19	1.8k	881	814	244	232	27	2.9k
Lina S. Sy United States	30	2.3k 1.3×	1.1k 1.2×	669 0.8×	123 0.5×	204 0.9×	124	3.6k
Sandra S. Chaves United States	37	4.2k 2.3×	1.3k 1.5×	722 0.9×	249 1.0×	250 1.1×	138	5.4k
Margaret L. Russell Canada	28	1.4k 0.8×	482 0.5×	514 0.6×	185 0.8×	151 0.7×	111	2.6k
Philip LaRussa United States	35	2.8k 1.5×	1.1k 1.2×	298 0.4×	194 0.8×	248 1.1×	123	3.9k
Stephanie A. Irving United States	23	1.2k 0.7×	605 0.7×	765 0.9×	202 0.8×	170 0.7×	71	2.2k
Penina Haber United States	27	1.7k 0.9×	1.3k 1.5×	906 1.1×	169 0.7×	164 0.7×	54	3.4k
Rafael Harpaz United States	40	5.1k 2.8×	1.3k 1.5×	1.3k 1.6×	417 1.7×	471 2.0×	95	6.9k
William Atkinson United States	18	1.4k 0.8×	709 0.8×	899 1.1×	249 1.0×	310 1.3×	36	2.6k
Paul Gargiullo United States	33	3.7k 2.1×	1.9k 2.1×	782 1.0×	289 1.2×	499 2.2×	73	5.9k
Javier Díez‐Domingo Spain	34	3.6k 2.0×	919 1.0×	540 0.7×	245 1.0×	334 1.4×	220	4.7k

Countries citing papers authored by Gina T. Mootrey

Since Specialization

Citations

This map shows the geographic impact of Gina T. Mootrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gina T. Mootrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gina T. Mootrey more than expected).

Fields of papers citing papers by Gina T. Mootrey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gina T. Mootrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gina T. Mootrey. The network helps show where Gina T. Mootrey may publish in the future.

Co-authorship network of co-authors of Gina T. Mootrey

This figure shows the co-authorship network connecting the top 25 collaborators of Gina T. Mootrey. A scholar is included among the top collaborators of Gina T. Mootrey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gina T. Mootrey. Gina T. Mootrey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lindley, Megan C., Suchita A. Lorick, Gina T. Mootrey, et al.. (2011). Student Vaccination Requirements of U.S. Health Professional Schools: A Survey. Annals of Internal Medicine. 154(6). 391–400. 38 indexed citations

Thomas, Tracy N., et al.. (2008). A Review of the Smallpox Vaccine Adverse Events Active Surveillance System. Clinical Infectious Diseases. 46(s3). S212–S220. 7 indexed citations

Morgan, Juliette, Martha H. Roper, Laurence Sperling, et al.. (2008). Myocarditis, Pericarditis, and Dilated Cardiomyopathy after Smallpox Vaccination among Civilians in the United States, January–October 2003. Clinical Infectious Diseases. 46(s3). S242–S250. 56 indexed citations

Ortega‐Sanchez, Ismael R., et al.. (2008). Economics of Cardiac Adverse Events after Smallpox Vaccination: Lessons from the 2003 US Vaccination Program. Clinical Infectious Diseases. 46(s3). S168–S178. 6 indexed citations

Neff, Linda J., et al.. (2008). Follow‐Up of Cardiovascular Adverse Events after Smallpox Vaccination among Civilians in the United States, 2003. Clinical Infectious Diseases. 46(s3). S251–S257. 16 indexed citations

Chapman, Louisa E., Gina T. Mootrey, & Linda J. Neff. (2008). Vaccination against Smallpox in the Posteradication Era. Clinical Infectious Diseases. 46(s3). S153–S156.

Orenstein, Walter A., Gina T. Mootrey, Karen Pazol, & A R Hinman. (2007). Financing Immunization of Adults in the United States. Clinical Pharmacology & Therapeutics. 82(6). 764–768. 20 indexed citations

Baggs, James, Robert T. Chen, Inger K. Damon, et al.. (2005). Safety Profile of Smallpox Vaccine: Insights from the Laboratory Worker Smallpox Vaccination Program. Clinical Infectious Diseases. 40(8). 1133–1140. 20 indexed citations

Haber, Penina, et al.. (2004). An Analysis of Rotavirus Vaccine Reports to the Vaccine Adverse Event Reporting System: More Than Intussusception Alone?. PEDIATRICS. 113(4). e353–e359. 29 indexed citations

10.

Haber, Penina, et al.. (2003). Adverse event reporting rates following tetanus–diphtheria and tetanus toxoid vaccinations: data from the Vaccine Adverse Event Reporting System (VAERS), 1991–1997. Vaccine. 21(25-26). 3746–3750. 23 indexed citations

11.

Zhou, Weigong, Vitali Pool, John K. Iskander, et al.. (2003). Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.. PubMed. 52(1). 1–24. 300 indexed citations

12.

Lathrop, Sarah, Robert Ball, Penina Haber, et al.. (2002). Adverse event reports following vaccination for Lyme disease: December 1998–July 2000. Vaccine. 20(11-12). 1603–1608. 56 indexed citations

13.

Wise, Robert P., M. Miles Braun, Jane F. Seward, et al.. (2002). Pharmacoepidemiologic implications of erroneous varicella vaccinations in pregnancy through confusion with Varicella zoster immune globulin. Pharmacoepidemiology and Drug Safety. 11(8). 651–654. 6 indexed citations

14.

Pool, Vitali, M. Miles Braun, John M. Kelso, et al.. (2002). Prevalence of Anti-Gelatin IgE Antibodies in People With Anaphylaxis After Measles-Mumps-Rubella Vaccine in the United States. PEDIATRICS. 110(6). e71–e71. 90 indexed citations

15.

Ball, Robert, et al.. (2001). Safety Data on Meningococcal Polysaccharide Vaccine from the Vaccine Adverse Event Reporting System. Clinical Infectious Diseases. 32(9). 1273–1280. 18 indexed citations

16.

Ellenberg, Susan S., et al.. (2001). The epidemiology of fatalities reported to the Vaccine Adverse Event Reporting System 1990–1997. Pharmacoepidemiology and Drug Safety. 10(4). 279–285. 26 indexed citations

17.

DeStefano, Frank, et al.. (2001). Challenges and Controversies in Immunization Safety. Infectious Disease Clinics of North America. 15(1). 21–39. 39 indexed citations

18.

Chen, Robert T., Gina T. Mootrey, & Frank DeStefano. (2000). Safety of Routine Childhood Vaccinations. Pediatric Drugs. 2(4). 273–290. 17 indexed citations

19.

Braun, M. Miles, et al.. (2000). Infant Immunization With Acellular Pertussis Vaccines in the United States: Assessment of the First Two Years' Data From the Vaccine Adverse Event Reporting System (VAERS). PEDIATRICS. 106(4). e51–e51. 55 indexed citations

20.

Kelso, John M., Gina T. Mootrey, & Theodore F. Tsai. (1999). Anaphylaxis from yellow fever vaccine. Journal of Allergy and Clinical Immunology. 103(4). 698–701. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact